Drugs.com
OCTOBER 3, 2024
3, 2024 -- Americans who turn to online pharmacies to find cheaper versions of expensive prescription medications, especially opioids, may instead be buying themselves dangerous drugs that could trigger an overdose, U.S. THURSDAY, Oct.
BioPharma Drive: Drug Pricing
MARCH 6, 2025
Phase 3 studies for Amgen’s closely watched obesity drug were posted on a federal database. Elsewhere, Novo started up an online pharmacy and the FDA cleared testing of a base editing therapy for Duchenne.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Policy Prescription
JANUARY 11, 2024
LegitScript argued that PharmacyChecker does not have antitrust standing because its business, providing information on the Internet that Americans use to find vetted international online pharmacies and compare their prices, is unlawful. First, people are not prosecuted for importing a prescription drug for their own use.
Policy Prescription
APRIL 19, 2023
the National Association of Boards of Pharmacy et al., in which PharmacyChecker alleges an unlawful “conspiracy involving front groups for Big Pharma” that keep “lower priced drugs out of reach of millions of Americans.” That research has identified PharmacyChecker as a company that properly credentials online pharmacies.
Policy Prescription
MARCH 11, 2022
A recent opinion from an appeals court in Manitoba, Canada sheds new and more favorable light about the CanadaDrugs-related wholesale drug importation case that was first covered a decade ago in the Wall Street Journal. for sales of mostly misbranded (but not counterfeit drugs) and two batches of counterfeit drugs. supply chain.
Policy Prescription
MAY 28, 2021
For the past decade, I’ve written extensively about my view that pharma-funded organizations and initiatives are responsible for misleading Americans about the safety of buying more affordable prescription drugs over the Internet for import from Canada and other countries. Here’s one example and you can be the judge.
FDA Law Blog: Biosimilars
JANUARY 22, 2024
Claud — The Office of Compliance (OC) at FDA’s Center for Drug Evaluation and Research (CDER) had a role in many of the major public health enforcement matters you may have read about last year. OC devoted a lot of resources to its compliance efforts directed at human drug compounding. Drug Supply Chain. By John W.M.
Expert insights. Personalized for you.
275 
Let's personalize your content